Deutsche Bank’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-572,311
| Closed | -$13.7M | – | 5007 |
|
|
2021
Q1 | $13.7M | Buy |
572,311
+508,822
| +801% | +$9.46M | 0.01% | 1045 |
|
|
2020
Q4 | $926K | Buy |
63,489
+19,612
| +45% | +$260K | ﹤0.01% | 2495 |
|
|
2020
Q3 | $624K | Sell |
43,877
-718,496
| -94% | -$11M | ﹤0.01% | 2501 |
|
|
2020
Q2 | $11.2M | Buy |
762,373
+635,690
| +502% | +$6.46M | 0.01% | 927 |
|
|
2020
Q1 | $522K | Sell |
126,683
-149,478
| -54% | -$701K | ﹤0.01% | 2459 |
|
|
2019
Q4 | $1.33M | Buy |
276,161
+16,879
| +7% | +$93.1K | ﹤0.01% | 2216 |
|
|
2019
Q3 | $1.57M | Sell |
259,282
-61,929
| -19% | -$386K | ﹤0.01% | 2054 |
|
|
2019
Q2 | $2.08M | Buy |
321,211
+38,725
| +14% | +$273K | ﹤0.01% | 2359 |
|
|
2019
Q1 | $2M | Buy |
282,486
+87,069
| +45% | +$573K | ﹤0.01% | 2504 |
|
|
2018
Q4 | $949K | Sell |
195,417
-171,852
| -47% | -$895K | ﹤0.01% | 2929 |
|
|
2018
Q3 | $2.7M | Buy |
367,269
+263,312
| +253% | +$1.93M | ﹤0.01% | 2659 |
|
|
2018
Q2 | $664K | Buy |
103,957
+31,448
| +43% | +$208K | ﹤0.01% | 3688 |
|
|
2018
Q1 | $393K | Sell |
72,509
-44,003
| -38% | -$219K | ﹤0.01% | 3844 |
|
|
2017
Q4 | $485K | Sell |
116,512
-26,029
| -18% | -$157K | ﹤0.01% | 3615 |
|
|
2017
Q3 | $1.37M | Sell |
142,541
-53,083
| -27% | -$551K | ﹤0.01% | 2793 |
|
|
2017
Q2 | $2.31M | Buy |
195,624
+17,401
| +10% | +$222K | ﹤0.01% | 2467 |
|
|
2017
Q1 | $2.28M | Buy |
178,223
+90,519
| +103% | +$1.09M | ﹤0.01% | 2161 |
|
|
2016
Q4 | $1.07M | Sell |
87,704
-72,368
| -45% | -$859K | ﹤0.01% | 2641 |
|
|
2016
Q3 | $1.89M | Sell |
160,072
-140,577
| -47% | -$1.36M | ﹤0.01% | 2389 |
|
|
2016
Q2 | $2.61M | Buy |
300,649
+44,708
| +17% | +$307K | ﹤0.01% | 2211 |
|
|
2016
Q1 | $1.35M | Sell |
255,941
-1,254
| -0.5% | -$6.98K | ﹤0.01% | 2614 |
|
|
2015
Q4 | $2M | Sell |
257,195
-2,008
| -0.8% | -$15.4K | ﹤0.01% | 2443 |
|
|
2015
Q3 | $2.04M | Buy |
259,203
+1,672
| +0.6% | +$15.5K | ﹤0.01% | 2477 |
|
|
2015
Q2 | $2.33M | Buy |
257,531
+7,981
| +3% | +$80.5K | ﹤0.01% | 2337 |
|
|
2015
Q1 | $3.24M | Buy |
249,550
+191,400
| +329% | +$2.5M | ﹤0.01% | 2096 |
|
|
2014
Q4 | $791K | Sell |
58,150
-20,315
| -26% | -$227K | ﹤0.01% | 3364 |
|
|
2014
Q3 | $703K | Sell |
78,465
-11,791
| -13% | -$127K | ﹤0.01% | 3264 |
|
|
2014
Q2 | $1.22M | Sell |
90,256
-21,657
| -19% | -$226K | ﹤0.01% | 2802 |
|
|
2014
Q1 | $1.11M | Buy |
111,913
+748
| +0.7% | +$9.29K | ﹤0.01% | 2790 |
|
|
2013
Q4 | $1.48M | Sell |
111,165
-143,843
| -56% | -$1.75M | ﹤0.01% | 2432 |
|
|
2013
Q3 | $3.09M | Buy |
255,008
+108,142
| +74% | +$1.16M | ﹤0.01% | 2171 |
|
|
2013
Q2 | $1.52M | Buy |
+146,866
| New | +$2.03M | ﹤0.01% | 2404 |
|
Deutsche Bank's GNMK Position: Q2 2021 in Review
Deutsche Bank sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 572,311 shares — an estimated $13.7M sold.
Deutsche Bank first reported a position in GNMK in Q2 2013 and held it in 32 quarters. The position peaked at $13.7M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Deutsche Bank reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Deutsche Bank sold 572,311 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $13.7M.
- Deutsche Bank first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 32 quarters.
- Deutsche Bank's GenMark Diagnostics, Inc position peaked at $13.7M in Q1 2021.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.